Risk factors for severe respiratory syncytial virus infection in infants

Y Aujard1, B Fauroux

  • 1Hopital Robert Debré, Assistance Publique-Hĵpitaux de Paris, France. yannick.aujard@rdb.ap-hop-paris.fr

Insights

Severe respiratory syncytial virus (RSV) disease poses significant risks to children, particularly those with underlying health conditions or environmental exposures. Prevention through infection control and prophylaxis is crucial for managing this serious illness in high-risk infants and children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Severe respiratory syncytial virus (RSV) disease causes significant illness and death in children, especially infants.
  • Risk factors include prematurity, congenital heart disease, immunosuppression, cystic fibrosis, crowding, day-care, and passive smoke exposure.
  • Current treatments for severe RSV are limited, highlighting the need for effective management strategies.

Purpose of the Study:

  • To review the risks and management of severe respiratory syncytial virus (RSV) disease in children.
  • To emphasize the importance of preventive measures for high-risk pediatric populations.

Main Methods:

  • This review synthesizes information on RSV disease burden, risk factors, and current management approaches.
  • Focuses on identifying effective preventive strategies for vulnerable children.

Main Results:

  • Children with specific underlying conditions and environmental exposures face increased risk of severe RSV.
  • Hospitalization for severe RSV strains healthcare resources and impacts families.
  • No curative treatments currently exist for severe RSV disease.

Conclusions:

  • Preventive measures, including infection control and prophylaxis, are the most effective strategies for managing severe RSV in high-risk children.
  • Early identification and intervention are critical for reducing morbidity and mortality associated with RSV.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...